251 related articles for article (PubMed ID: 29476041)
1. CYP26C1 Is a Hydroxylase of Multiple Active Retinoids and Interacts with Cellular Retinoic Acid Binding Proteins.
Zhong G; Ortiz D; Zelter A; Nath A; Isoherranen N
Mol Pharmacol; 2018 May; 93(5):489-503. PubMed ID: 29476041
[TBL] [Abstract][Full Text] [Related]
2. A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid.
Taimi M; Helvig C; Wisniewski J; Ramshaw H; White J; Amad M; Korczak B; Petkovich M
J Biol Chem; 2004 Jan; 279(1):77-85. PubMed ID: 14532297
[TBL] [Abstract][Full Text] [Related]
3. CRABPs Alter
Yabut KCB; Isoherranen N
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565751
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and physiological importance of the CYP26 retinoic acid hydroxylases.
Isoherranen N; Zhong G
Pharmacol Ther; 2019 Dec; 204():107400. PubMed ID: 31419517
[TBL] [Abstract][Full Text] [Related]
5. Induction of CYP26A1 by metabolites of retinoic acid: evidence that CYP26A1 is an important enzyme in the elimination of active retinoids.
Topletz AR; Tripathy S; Foti RS; Shimshoni JA; Nelson WL; Isoherranen N
Mol Pharmacol; 2015; 87(3):430-41. PubMed ID: 25492813
[TBL] [Abstract][Full Text] [Related]
6. Functional properties and substrate characterization of human CYP26A1, CYP26B1, and CYP26C1 expressed by recombinant baculovirus in insect cells.
Helvig C; Taimi M; Cameron D; Jones G; Petkovich M
J Pharmacol Toxicol Methods; 2011; 64(3):258-63. PubMed ID: 21906690
[TBL] [Abstract][Full Text] [Related]
7. Direct protein-protein interactions and substrate channeling between cellular retinoic acid binding proteins and CYP26B1.
Nelson CH; Peng CC; Lutz JD; Yeung CK; Zelter A; Isoherranen N
FEBS Lett; 2016 Aug; 590(16):2527-35. PubMed ID: 27416800
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the function and expression of CYP26A1 and CYP26B1, the two retinoic acid hydroxylases.
Topletz AR; Thatcher JE; Zelter A; Lutz JD; Tay S; Nelson WL; Isoherranen N
Biochem Pharmacol; 2012 Jan; 83(1):149-63. PubMed ID: 22020119
[TBL] [Abstract][Full Text] [Related]
9. Cellular retinoid-binding proteins transfer retinoids to human cytochrome P450 27C1 for desaturation.
Glass SM; Guengerich FP
J Biol Chem; 2021 Oct; 297(4):101142. PubMed ID: 34480899
[TBL] [Abstract][Full Text] [Related]
10. Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells.
Ozpolat B; Mehta K; Lopez-Berestein G
Leuk Lymphoma; 2005 Oct; 46(10):1497-506. PubMed ID: 16194896
[TBL] [Abstract][Full Text] [Related]
11. Knockout of Cyp26a1 and Cyp26b1 during postnatal life causes reduced lifespan, dermatitis, splenomegaly, and systemic inflammation in mice.
Snyder JM; Zhong G; Hogarth C; Huang W; Topping T; LaFrance J; Palau L; Czuba LC; Griswold M; Ghiaur G; Isoherranen N
FASEB J; 2020 Dec; 34(12):15788-15804. PubMed ID: 33105029
[TBL] [Abstract][Full Text] [Related]
12. Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1.
Foti RS; Isoherranen N; Zelter A; Dickmann LJ; Buttrick BR; Diaz P; Douguet D
J Pharmacol Exp Ther; 2016 May; 357(2):281-92. PubMed ID: 26937021
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective formation and metabolism of 4-hydroxy-retinoic Acid enantiomers by cytochrome p450 enzymes.
Shimshoni JA; Roberts AG; Scian M; Topletz AR; Blankert SA; Halpert JR; Nelson WL; Isoherranen N
J Biol Chem; 2012 Dec; 287(50):42223-32. PubMed ID: 23071109
[TBL] [Abstract][Full Text] [Related]
14. Molecular and metabolic retinoid pathways in the human ocular surface.
Nezzar H; Chiambaretta F; Marceau G; Blanchon L; Faye B; Dechelotte P; Rigal D; Sapin V
Mol Vis; 2007 Sep; 13():1641-50. PubMed ID: 17893666
[TBL] [Abstract][Full Text] [Related]
15. Expression of retinoic acid-metabolizing enzymes, ALDH1A1, ALDH1A2, ALDH1A3, CYP26A1, CYP26B1 and CYP26C1 in canine testis during post-natal development.
Kasimanickam VR
Reprod Domest Anim; 2016 Dec; 51(6):901-909. PubMed ID: 27569851
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
Cornic M; Guidez F; Delva L; Agadir A; Degos L; Chomienne C
Bull Cancer; 1992; 79(7):697-704. PubMed ID: 1334741
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of the retinoic acid-metabolizing enzyme CYP26C1 in primary breast carcinomas.
Osanai M; Lee GH
Med Mol Morphol; 2016 Mar; 49(1):22-7. PubMed ID: 26009309
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the
Stevison F; Hogarth C; Tripathy S; Kent T; Isoherranen N
Drug Metab Dispos; 2017 Jul; 45(7):846-854. PubMed ID: 28446509
[No Abstract] [Full Text] [Related]
19. Molecular recognition of CYP26A1 binding pockets and structure-activity relationship studies for design of potent and selective retinoic acid metabolism blocking agents.
Sun B; Song S; Hao CZ; Huang WX; Liu CC; Xie HL; Lin B; Cheng MS; Zhao DM
J Mol Graph Model; 2015 Mar; 56():10-9. PubMed ID: 25541526
[TBL] [Abstract][Full Text] [Related]
20. Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis.
Pavez Loriè E; Cools M; Borgers M; Wouters L; Shroot B; Hagforsen E; Törmä H; Vahlquist A
Br J Dermatol; 2009 Jan; 160(1):26-36. PubMed ID: 19016711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
